Saltar al contenido
República del Perú · Observatorio de la producción científica universitaria
OApol.org Observatorio de Inteligencia Científica Universitaria del Perú
OApol.org
Inicio Universidades Publicaciones Investigadores
Repositorios
Tesis y trabajos académicosRevistas
Indicadores
Ranking trimestralRanking por carreraObjetivos de Desarrollo SostenibleReporte OCDERed neuronal 3D
Acerca
MetodologíaPrivacidad

SatO2/FiO2 rate versus PaO2/FiO2 rate for predicting mortality in patients with COVID-19 in a high-altitude hospital

Marmanillo-Mendoz G.; Zuñiga-Manriqu R.; Cornejo-DelVall O.; Canqui L.P. · Acta Medica Peruana (2021) · DOI: 10.35663/amp.2021.384.2033

Resumen

Objective: To compare the SatO2/FiO2 rate against PaO2/FiO2 rate for predicting mortality in COVID-19 patients in a high altitude hospital. Materials and Methods: This is an observational, retrospective, and cross-sectional study, where sensitivity (S), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) for both rates were compared. Results: The average age of COVID-19 patients was 62.2 ± 12.8 years. Three quarters (73.7 %) of all patients were male, most frequent comorbidities were diabetes mellitus (21.6 %), and high blood pressure (27.2 %). On the other hand, average SatO2/FiO2 rate was 234.9 ± 121.9, and PaO2/FiO2 was 169.7 ± 84, and 30.5 % of all patients died. A significant relationship between the aforementioned rates and mortality was evidenced. The cutoff point for SatO2/FiO2 was 114.4, with 43.1 % sensitivity, 91.2 % specificity, 68.3 % positive predictive value, and 78.5 % negative predictive value. The cutoff point for PaO2/FiO2 was 134.2, with 63.1 % sensitivity, 67.6 % specificity, 46.1 % positive predictive value, and 80.7 % negative predictive value. Conclusion: Both rates are predictors for mortality; however, SatO2/FiO2 showed better results with respect to the following parameters: sensitivity, specificity, positive predictive value, and negative predictive value. © Inra Productions Animales.All rights reserved.